- $85.04m
- $222.69m
- $22.18m
- 30
- 78
- 35
- 45
Annual balance sheet for Phenixfin, fiscal year end - September 30th, USD millions except per share, conversion factor applied.
2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | 2024 September 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 56.5 | 69.4 | 22.8 | 5.99 | 67.6 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.744 | 2.62 | 1.42 | 5.51 | 4.45 |
| Prepaid Expenses | |||||
| Net Property, Plant And Equipment | — | 0.614 | 0.513 | 0.45 | 0.322 |
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Other Assets | |||||
| Total Assets | 306 | 225 | 219 | 240 | 303 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 155 | 81.4 | 98 | 93 | 142 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 151 | 144 | 121 | 147 | 160 |
| Total Liabilities & Shareholders' Equity | 306 | 225 | 219 | 240 | 303 |
| Total Common Shares Outstanding |